Ledger.Open graph →
SEC Form D · filed June 30, 2023

TwinStrand Biosciences, Inc

Offering
$25.7M
Sold
$10.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Karen Dabbs · Seattle, WAExecDavid Canner · Mendham, NJDirectorSoma Somasegar · SEATTLE, WADirectorChad Waite · Seattle, WADirectorChad Waite · Somerville, MADirectorMike Pellini · Los Angeles, CADirectorMike Pellini · Los Angeles, CADirectorJason Myers · Redwood City, CADirectorDavid Canner · Mendham, NJDirectorKaren Dabbs · Seattle, WAExecSoma Somasegar · SEATTLE, WADirectorJason Myers · Davie, FLDirectorRonnie Andrews · Alpharetta, GAExecRonnie Andrews · SEATTLE, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗